Bisveda-H 10mg/6.25mg Tablet

Introduction

Bisveda-H is a medication that combines two active ingredients: Bisoprolol and Hydrochlorothiazide. It is available in tablet form and is commonly prescribed to manage certain cardiovascular conditions.

Uses

Bisveda-H is primarily used to treat hypertension (high blood pressure) and heart failure. It is often prescribed when a combination of medications is needed to effectively manage these conditions.

Dosage and Administration

The dosage of Bisveda-H may vary depending on the individual’s specific condition and medical history. Follow the instructions provided by your healthcare professional. Typically, the initial dose is one tablet per day, which may be increased gradually if necessary. The tablet should be taken orally with a glass of water, preferably at the same time each day.

Mechanism of Action

Bisoprolol, one of the active ingredients in Bisveda-H, belongs to a class of medications called beta blockers. It works by blocking certain receptors in the heart, which helps to reduce heart rate and blood pressure. Hydrochlorothiazide is a diuretic, which means it helps the body eliminate excess fluid and salt through increased urine production. This helps to lower blood pressure as well.

Side Effects

Common side effects may include fatigue, dizziness, headache, and gastrointestinal disturbances such as nausea or upset stomach. These side effects are usually mild and temporary. However, if you experience any severe or persistent side effects, consult your healthcare professional.

Drug Interactions

Bisveda-H may interact with certain medications, including other blood pressure-lowering medications, nonsteroidal anti-inflammatory drugs (NSAIDs), certain antidepressants, and medications that affect potassium levels. Inform your healthcare professional about all the medications you are currently taking to avoid potential interactions.

Precautions

Before taking Bisveda-H, inform your healthcare professional about any existing medical conditions, including kidney or liver problems, asthma, diabetes, or any allergies. This medication may not be suitable for everyone, and your healthcare professional will determine if it is appropriate for you. Avoid alcohol consumption while taking Bisveda-H, as it may enhance the sedative effects of the medication.

Storage

Bisveda-H should be stored at room temperature, away from direct sunlight and moisture. Keep it out of reach of children and pets. Do not use the medication if it has expired or if the packaging is damaged.

Patient Tips

• Take Bisveda-H exactly as prescribed by your healthcare professional.
• Do not stop taking the medication without consulting your healthcare professional, as abruptly stopping it may cause an increase in blood pressure or other adverse effects.
• If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and resume your regular dosing schedule.
• have regular check-ups with your healthcare professional to monitor your response to the medication and assess any potential side effects.
• If you have any questions or concerns about Bisveda-H or its use, consult your healthcare professional for further guidance.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Bisoprolol: medicine to treat high blood pressure (hypertension) (NHS UK) [Accessed 19 Jun. 2024] (online) Available at:
• Bisoprolol 1.25mg film-coated tablets (Health Professionals SmPC) Available at:
• Bisoprolol (Drugs.com) [Accessed 4 Jun. 2024] (online) Available at:
• bisoprolol (RX) [Accessed 6 Jun. 2024] (online) Available at:
• Bisoprolol (MedlinePlus) [Accessed 6 Jun. 2024] (online) Available at:
• Muresan L, Cismaru G, Muresan C, Rosu R, Gusetu G, Puiu M, Mada RO, Martins RP. Beta-blockers for the treatment of arrhythmias: Bisoprolol – a systematic review. Ann Pharm Fr. 2022 Sep;80(5):617-634. doi: 10.1016/j.pharma.2022.01.007. Epub 2022 Jan 31. [Accessed 19 Jun. 2024] Available at: